{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:16:51Z","timestamp":1761513411106,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.cllc.2013.12.011","type":"journal-article","created":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T11:15:45Z","timestamp":1390562145000},"page":"294-301.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Imaging Features Associated With Disease Progression After Stereotactic Ablative Radiotherapy for Stage I Non\u2013Small-Cell Lung Cancer"],"prefix":"10.1016","volume":"15","author":[{"given":"David B.","family":"Shultz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Trakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A.","family":"Abelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G.","family":"Maxim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quynh-Thu","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Billy W.","family":"Loo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Diehn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2013.12.011_bib1","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S1470-2045(12)70242-5","article-title":"Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non\u2013small-cell lung cancer: a retrospective analysis","volume":"13","author":"Senthi","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2013.12.011_bib2","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Small Cell Lung Cancer Version 2.2013. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nscl.pdf. Accessed: October 3, 2013."},{"key":"10.1016\/j.cllc.2013.12.011_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/CCO.0b013e328341ee11","article-title":"Stereotactic radiation therapy: changing treatment paradigms for stage I non\u2013small-cell lung cancer","volume":"23","author":"Palma","year":"2011","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.cllc.2013.12.011_bib4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/JTO.0b013e31818307a7","article-title":"Relationship between non\u2013small-cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index","volume":"3","author":"Vesselle","year":"2008","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2013.12.011_bib5","first-page":"767","article-title":"Relationship between pleural indentation on computed tomography scans and pleural invasion in small peripheral lung cancer of 2 cm in size or less","volume":"62","author":"Saito","year":"2009","journal-title":"Kyobu Geka"},{"key":"10.1016\/j.cllc.2013.12.011_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijrobp.2011.10.071","article-title":"Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors","volume":"84","author":"Trakul","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2013.12.011_bib7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ijrobp.2007.10.059","article-title":"Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy","volume":"70","author":"Park","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2013.12.011_bib8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijrobp.2007.04.036","article-title":"Metabolic tumor burden predicts for disease progression and death in lung cancer","volume":"69","author":"Lee","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2013.12.011_bib9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1148\/radiol.12120864","article-title":"Use of CT to evaluate pleural invasion in non\u2013small-cell lung cancer: measurement of the ratio of the interface between tumor and neighboring structures to maximum tumor diameter","volume":"267","author":"Imai","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.cllc.2013.12.011_bib10","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2013.12.011_bib11","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jtcvs.2006.05.023","article-title":"Location as an important predictor of lymph node involvement for pulmonary adenocarcinoma","volume":"132","author":"Ketchedjian","year":"2006","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"suppl 10","key":"10.1016\/j.cllc.2013.12.011_bib12","doi-asserted-by":"crossref","first-page":"x52","DOI":"10.1093\/annonc\/mds347","article-title":"Developments in the treatment of early NSCLC: when to use chemotherapy","volume":"23","author":"Besse","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2013.12.011_bib13","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1200\/JCO.2008.16.4855","article-title":"Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non\u2013small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group study groups","volume":"26","author":"Strauss","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2013.12.011_bib14","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.jtcvs.2012.03.039","article-title":"Adjuvant chemotherapy for surgically resected non\u2013small-cell lung cancer","volume":"144","author":"Heon","year":"2012","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2013.12.011_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lungcan.2008.07.006","article-title":"Preoperative evaluation of the depth of chest wall invasion and the extent of combined resections in lung cancer patients","volume":"64","author":"Kawaguchi","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2013.12.011_bib16","first-page":"332","article-title":"Mediastinal lymph node metastasis pattern in clinically N0 non-small-cell lung cancer patients who underwent surgical resection","volume":"64","author":"Krdzalic","year":"2010","journal-title":"Med Arh"},{"key":"10.1016\/j.cllc.2013.12.011_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/JTO.0b013e31815e6d6b","volume":"3","author":"Berghmans","year":"2008","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2013.12.011_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.radonc.2012.04.019","article-title":"Stereotactic body radiotherapy (SBRT) for non\u2013small-cell lung cancer (NSCLC): is FDG-PET a predictor of outcome?","volume":"104","author":"Clarke","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cllc.2013.12.011_bib19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.lungcan.2012.12.023","article-title":"Long-term clinical experience of high-dose ablative lung radiotherapy: high pre-treatment [18F]fluorodeoxyglucose-positron emission tomography maximal standardized uptake value of the primary tumor adversely affects treatment outcome","volume":"80","author":"Lee","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2013.12.011_bib20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1748-717X-7-152","article-title":"Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non\u2013small-cell lung cancer","volume":"7","author":"Chang","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.cllc.2013.12.011_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.lungcan.2012.08.016","article-title":"Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy","volume":"78","author":"Abelson","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2013.12.011_bib22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ijrobp.2009.09.081","article-title":"Maximum standardized uptake value from staging FDG-PET\/CT does not predict treatment outcome for early-stage non\u2013small-cell lung cancer treated with stereotactic body radiotherapy","volume":"78","author":"Burdick","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2013.12.011_bib23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.lungcan.2006.12.009","article-title":"FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non\u2013small-cell lung cancer","volume":"56","author":"Hoopes","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2013.12.011_bib24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuroimage.2009.01.057","article-title":"Reducing between scanner differences in multi-center PET studies","volume":"46","author":"Joshi","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.cllc.2013.12.011_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/COC.0b013e3180ca77d1","article-title":"A\u00a0clinical model to estimate recurrence risk in resected stage I non\u2013small-cell lung cancer","volume":"31","author":"Goodgame","year":"2008","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.cllc.2013.12.011_bib26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.radonc.2008.07.013","article-title":"Dose-individualized stereotactic body radiotherapy for T1-3N0 non\u2013small-cell lung cancer: long-term results and efficacy of adjuvant chemotherapy","volume":"88","author":"Chen","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cllc.2013.12.011_bib27","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1200\/JCO.2012.44.5064","article-title":"New radiotherapy and chemoradiotherapy approaches for non\u2013small-cell lung cancer","volume":"31","author":"Salama","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2013.12.011_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijrobp.2007.06.043","article-title":"Steep dose-response relationship for\u00a0stage I non\u2013small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy","volume":"70","author":"Onimaru","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2013.12.011_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1748-717X-5-81","article-title":"Clinical outcomes of stereotactic body radiotherapy for stage I non\u2013small-cell lung cancer using different doses depending on tumor size","volume":"5","author":"Baba","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.cllc.2013.12.011_bib30","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.radonc.2013.10.012","article-title":"Correlation of dose computed using different\u00a0algorithms with local control following stereotactic ablative radiotherapy (SABR)-based treatment of non\u2013small-cell lung cancer","volume":"109","author":"Chetty","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cllc.2013.12.011_bib31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.radonc.2011.06.009","article-title":"Stereotactic radiotherapy of histologically proven inoperable stage I non\u2013small-cell lung cancer: patterns of failure","volume":"101","author":"Andratschke","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cllc.2013.12.011_bib32","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ijrobp.2009.06.017","article-title":"Stereotactic body radiation therapy for early-stage non\u2013small-cell lung cancer: the pattern of failure is distant","volume":"77","author":"Bradley","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730414000230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730414000230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:03:59Z","timestamp":1761505439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730414000230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1525730414000230"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2013.12.011","relation":{},"ISSN":["1525-7304"],"issn-type":[{"type":"print","value":"1525-7304"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging Features Associated With Disease Progression After Stereotactic Ablative Radiotherapy for Stage I Non\u2013Small-Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2013.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}